An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors

Clinical trial NCT01413893 · COMPLETED

Trial details

NCT number: NCT01413893
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2011-06-01
Primary completion: 2012-06-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.